Associations of C-reactive protein/albumin ratio with frailty and the risk of mortality: An observational study

C反应蛋白/白蛋白比值与虚弱和死亡风险的相关性:一项观察性研究

阅读:1

Abstract

Patients with frailty still have a high risk of postoperative death even after undergoing medium and low stress surgeries. Early and effective identification of frailty helps improve the poor prognosis of those who need surgery. This study aims to explore the relationship between C-reactive protein/albumin ratio (CAR) and frailty and the risk of mortality. The clinical data of 14,743 participants in National Health and Nutrition Examination Survey were analyzed. The weighted logistic regression model was used to estimate the odds ratios of CAR and frailty. The weighted Cox regression model was used to estimate the hazard ratios of CAR and all-cause mortality, cardiovascular disease (CVD)-specific mortality, and cancer-specific mortality of frail participants. In addition, the nonlinearity of the above associations was evaluated and subgroup analysis was performed. The fully adjusted weighted logistic regression model showed a positive correlation between CAR and frailty [odds ratio (95% confidence interval [CI]): 1.23 (1.15-1.31), P < .0001]; restricted cubic spline regression indicated that this association was linear (nonlinear P = .059). Subgroup analysis suggested that the association between CAR and frailty was stronger in hypertension and CVD. In survival analysis, CAR significantly predicted all-cause mortality [hazard ratio [HR] (95% CI): 1.12 (1.05-1.20), P = .001], CVD-specific mortality [HR (95% CI): 1.18 (1.06-1.32), P = .003], and cancer-specific mortality [HR (95% CI): 1.12 (1.01-1.24), P = .03] in frail participants. CAR is independently and linearly positively correlated with frailty. In addition, an increase in CAR in frail participants also indicates a higher risk of death.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。